| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 278.056.926 $ | -55.384.127 $ | -12,7 % | 321.499.009 $ | +85.730.262 $ | +57,2 % | 262.612.239 $ | +83.557.153 $ | +183,8 % | |
| GILEAD SCIENCES, INC. | 125.024.600 $ | -28.203.748 $ | -18,4 % | 153.228.348 $ | +37.890.338 $ | +32,9 % | 115.338.010 $ | +75.302.395 $ | +188,1 % |
| RA CAPITAL MANAGEMENT, L.P. | 28.316.378 $ | -6.387.766 $ | -18,4 % | 34.704.144 $ | +8.581.648 $ | +32,9 % | 26.122.496 $ | ||
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 34.065.623 $ | +2.639.319 $ | +8,4 % | 31.426.304 $ | |||||
| Commodore Capital LP | 27.750.000 $ | -6.260.000 $ | -18,4 % | 34.010.000 $ | +8.410.000 $ | +32,9 % | 25.600.000 $ | ||
| Janus Henderson Group Ltd. | 23.479.147 $ | -5.060.579 $ | -17,7 % | 28.539.726 $ | +9.313.895 $ | +48,4 % | 19.225.831 $ | ||
| Paradigm Biocapital Advisors LP | 18.460.715 $ | -4.164.472 $ | -18,4 % | 22.625.187 $ | |||||
| Point72 Asset Management, L.P. | 9.548.914 $ | -10.877.798 $ | -53,3 % | 20.426.712 $ | +12.848.670 $ | +169,6 % | |||
| VANGUARD GROUP INC | 19.484.260 $ | +6.630.193 $ | +51,6 % | 12.854.067 $ | +8.254.758 $ | +179,5 % | |||
| Frazier Life Sciences Management, L.P. | 11.679.974 $ | ||||||||
| Parkman Healthcare Partners LLC | 11.411.549 $ | +2.930.917 $ | +34,6 % | 8.480.632 $ | +2.055.518 $ | +32,0 % | |||
| FRANKLIN RESOURCES INC | 11.410.677 $ | ||||||||
| Caption Management, LLC | 8.954.880 $ | ||||||||
| 278.056.926 $ | -55.384.127 $ | -12,7 % | 321.499.009 $ | +85.730.262 $ | +57,2 % | 262.612.239 $ | +83.557.153 $ | +183,8 % | |